- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04254458
Corneal Densitometry in Acute Primary Angle Closure Glaucoma
Laser Peripheral Iridotomy Induced Changes in Corneal Densitometry in Acute Primary Angle Closure Glaucoma Cases
Purpose: Our purpose was to investigate the laser peripheral iridotomy (LPI) induced changes in corneal densitometry in acute primary angle closure glaucoma (PACG) cases during the post-laser 1 month period.
Material and methods: This prospective study included 21 eyes of 21 cases with first acute attack of PACG. All the eyes underwent LPI with neodymium: yttrium-aluminum-garnet (Nd: YAG) laser after the intraocular pressure (IOP) decreased to normal levels with maximal systemic and topical anti-glaucoma treatment and complete regression of clinically significant corneal edema. Central corneal thickness (CCT) and corneal density values were measured by densitometry software of Pentacam HR-Scheimpflug corneal topography over a 12-mm diameter of the cornea just before LPI and at the first week and the first month after LPI. Kolmogorov smirnov and paired-t tests were used for statistical analysis.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This prospective study included 21 eyes of 21 cases with first acute attack of PACG who had applied to emergency department of Ulucanlar Eye Research Hospital between March 2018 and January 2019. All the eyes underwent LPI with neodymium: yttrium-aluminum-garnet (Nd: YAG) laser after the IOP decreased to normal levels with maximal systemic and topical anti-glaucoma treatment and complete regression of clinically significant corneal edema.
During the acute attack ocular examination was performed at the emergency department including best-corrected visual acuity (BCVA) with Snellen charts, slit-lamb examination, fundus examination by +90 D lens, IOP measurements with Goldmann applanation tonometry, gonioscopy of the fellow eye with Goldmann three-mirror lens. Gonioscopy and fundus examinations were performed for the eyes with acute PACG after the regression of corneal edema.
All the cases had intravenous infusion of mannitol 20% (250-300 cc) at the emergency department. Oral acetazolamide 250 mg (3 times daily), oral potassium supplement, topical fixed-combination of beta-blocker and carbonic anhydrase inhibitors (twice daily) and brimonidine (twice daily). LPI procedures were performed within the first day of the attack (after 12-24 hours) by the same experienced physician (OA) with neodymium: yttrium-aluminum-garnet (Nd: YAG) laser under topical anesthesia with proparacain %0.5. Superior-nasal position (1 or 11 o'clock) was focused and 1 or more shots were performed (1-3 pulses per shot with 3-8 mJ energy).
Central corneal thickness (CCT) and CD values were measured by densitometry software of Pentacam HR-Scheimpflug corneal topography just before LPI and at the first week and the first month after LPI. All the measurements were performed by the same experienced clinician between 9 am and 2 pm under standard dim-light conditions without pupil dilatation.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Altindag
-
Ankara, Altindag, Turkey, 06240
- Ufuk Elgin
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Acute primary angle closure glaucoma cases with first attack
- high IOP (>40 mmHg)
- corneal edema
- red eye
- mid-dilated pupil
- presence of the symptoms like blurred vision, halos, ocular pain, headache, nausea and vomiting
Exclusion Criteria:
- The cases who had histories of any types of glaucoma or increased IOP before
- any corneal diseases like keratokonus
- corneal opacity
- dry eye or any ocular surface diseases
- ocular surgery or laser treatment
- trauma
- uveitis or other inflammation and contact lens use and diabetic cases were excluded
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
PACG group
Cases who had first acute attack of primary angle closure glaucoma
|
Corneal density values were measured by densitometry software of Pentacam HR-Scheimpflug corneal topography
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Measurement of corneal density by Pentacam HR-Scheimpflug corneal topography
Time Frame: 1 month
|
The measurements were done between 9 am and 2 pm under standard dim-light conditions without pupil dilatation.
The CD values of anterior layer (anterior 120 µm), central (between anterior layer and posterior 60 µm), posterior layer (posterior 60 µm) of 4 annular concentric zones as 0-2 mm zone, 2-6 mm zone, 6-10 mm zone and 10-12 mm zone were measured.
The CD values were expressed in grayscale units (GSC) as 0 for maximum transparency and 100 for total corneal opacity.
Measurement were done just before laser treatment and repeated at the first week and month.
|
1 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Measurement of central corneal thickness by Pentacam HR-Scheimpflug corneal topography
Time Frame: 1 month
|
The measurements were done between 9 am and 2 pm under standard dim-light conditions without pupil dilatation.
The central corneal thickness measurements just before laser treatment and at the first week and the first month.
|
1 month
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- E-18-1866
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Primary Angle-closure Glaucoma
-
National University Hospital, SingaporeCompletedChronic Angle Closure Glaucoma | Primary Angle Closure | Primary Angle Closure Suspect | Fellow Eyes of Acute Angle Closure GlaucomaSingapore
-
Taipei Medical University WanFang HospitalCompletedGlaucoma | Acute Primary Angle-closure GlaucomaTaiwan
-
Joint Shantou International Eye Center of Shantou...CompletedPrimary Angle-Closure Glaucoma | Acute Ocular Hypertension Glaucoma | Intraocular HypertensionChina
-
Khoo Teck Puat HospitalCompletedPrimary Angle-Closure Glaucoma | Primary Angle Closure Without Glaucoma DamageSingapore
-
Omar SaidCompletedGlaucoma,Primary Open-Angle ,Primary Angle ClosureEgypt
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityNot yet recruitingPrimary Angle-Closure Glaucoma
-
Asian Eye InstituteIvantis, Inc.CompletedPrimary Angle Closure Glaucoma | Primary Angle ClosurePhilippines
-
Quark PharmaceuticalsCompletedGlaucoma, Angle-closure, Primary, AcuteSingapore, United States, Vietnam
-
Peking University People's HospitalRecruiting
-
Peking University People's HospitalRecruitingPrimary Angle-closure GlaucomaChina
Clinical Trials on Corneal densitometry
-
Centre Hospitalier Universitaire, AmiensWithdrawnLymphoma | OsteoporosisFrance
-
University Tunis El ManarNot yet recruitingSarcopenia | Juvenile Idiopathic Arthritis
-
Centre Hospitalier Régional d'OrléansCompletedBone Mineral Density | Grip Strength | Physical PerformanceFrance
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityNot yet recruiting
-
Prim. Prof. Dr. Oliver Findl, MBACompleted
-
Fundación para la Investigación del Hospital Clínico...CompletedBreast Cancer | OsteopeniaSpain
-
Centre hospitalier de l'Université de Montréal...AllerganCompletedGlaucoma, Open-Angle | Glaucoma, Angle-Closure | Glaucoma Eye | Glaucoma SecondaryCanada
-
Centre Hospitalier Universitaire de NiceCompleted
-
Chang Gung Memorial HospitalUnknownHead and Neck Neoplasms | Malnutrition | Dual-Energy X-Ray AbsorptiometryTaiwan
-
CooperVision International Limited (CVIL)Completed